Chuen-Fu Lin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Chuen-Fu Lin has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Che-Kuan Lin
Feng Chia University, Department of Automatic Control Engineering, Taichung, Taiwan
2 shared publications - Chien-Teng Lin
Department of Veterinary Medicine, National Chiayi University, 580 Xinmin Road, Chiayi 60054, Taiwan
2 shared publications - Chih-Lang Lin
Central Taiwan University of Science and Technology
2 shared publications - Chung-Han Chiang
Graduate Institute of Biotechnology and Biomedical Engineering, Central Taiwan University of Science and Technology, Taichung City 40601, Taiwan
2 shared publications - Geng-Ruei Chang
Department of Veterinary Medicine, National Chiayi University, 580 Xinmin Road, Chiayi 60054, Taiwan
2 shared publications - Ming-Jeng Pan
Central Taiwan University of Science and Technology, Graduate Institute of Biotechnology, Taichung, Taiwan
2 shared publications
Latest Publications
- 23 May 2020
- Published by Springer Nature in Archives of Microbiology
- Vol. 202 (7) , 1849-1860
Potential probiotic of Lactobacillus strains isolated from the intestinal tracts of pigs and feces of dogs with antibacterial activity against multidrug-resistant pathogenic bacteria
The occurrence of multidrug-resistant pathogenic bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA), multidrug-resistant Acinetobacter baumannii (MDRAB), extended-spectrum β-lactamase (ESBL) Escherichia coli, and Pseudomonas aeruginosa, has become a serious problem in animals and public. The objective of this study was to identify and isolate lactic acid bacterial (LAB) strains from the intestinal tracts of pigs and feces of dogs and then characterize them as potential probiotics with antimicrobial activity against multidrug-resistant pathogenic bacteria. In a preliminary isolation screening, 45 of 1167 isolated LAB strains were found to have anti-S. aureus ATCC 27,735 activity. Using 16S rDNA and 16S-23S rDNA intergenic spacer region (ISR) sequences, five of these isolates were further identified as Lactobacillus animalis 30a-2, Lactobacillus reuteri 4-12E, Weissella cibaria C34, Lactococcus lactis 5-12H, and Lactococcus lactis 6-3H. Antimicrobial substance assays suggest that the L. lactis 5-12H, L. lactis 6-3H, L. animalis 30a-2, L. reuteri 4-12E, and W. cibaria C34 strains might produce bacteriocins and hydrogen peroxide (H2O2) as antimicrobial substances. The L. animalis 30a-2 and W. cibaria C34 strains were further characterized for probiotic properties and shown to have high acid and bile salt tolerance. Additionally, they have broad antimicrobial spectra, and can significantly repress the growth of all of the tested strains of MRSA isolates, some MDRAB, ESBL E. coli, and P. aeruginosa isolates, along with food-borne pathogenic bacteria such as Bacillus cereus ATCC 11778, Listeria monocytogens ATCC 19111, Salmonella spp., Shigella spp., and Yersinia enterocolitica BCRC 12986. This is the first report of H2O2-producing L. animalis 30a-2 and W. cibaria C34 isolated from the intestinal tracts of pigs and feces of dogs that have good antimicrobial activity against multidrug-resistant and food-borne pathogenic bacteria and have excellent probiotic properties.
- 23 May 2020
- Published by Springer Nature in Archives of Microbiology
- Vol. 202 (7) , 1849-1860
Potential probiotic of Lactobacillus strains isolated from the intestinal tracts of pigs and feces of dogs with antibacterial activity against multidrug-resistant pathogenic bacteria
The occurrence of multidrug-resistant pathogenic bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA), multidrug-resistant Acinetobacter baumannii (MDRAB), extended-spectrum β-lactamase (ESBL) Escherichia coli, and Pseudomonas aeruginosa, has become a serious problem in animals and public. The objective of this study was to identify and isolate lactic acid bacterial (LAB) strains from the intestinal tracts of pigs and feces of dogs and then characterize them as potential probiotics with antimicrobial activity against multidrug-resistant pathogenic bacteria. In a preliminary isolation screening, 45 of 1167 isolated LAB strains were found to have anti-S. aureus ATCC 27,735 activity. Using 16S rDNA and 16S-23S rDNA intergenic spacer region (ISR) sequences, five of these isolates were further identified as Lactobacillus animalis 30a-2, Lactobacillus reuteri 4-12E, Weissella cibaria C34, Lactococcus lactis 5-12H, and Lactococcus lactis 6-3H. Antimicrobial substance assays suggest that the L. lactis 5-12H, L. lactis 6-3H, L. animalis 30a-2, L. reuteri 4-12E, and W. cibaria C34 strains might produce bacteriocins and hydrogen peroxide (H2O2) as antimicrobial substances. The L. animalis 30a-2 and W. cibaria C34 strains were further characterized for probiotic properties and shown to have high acid and bile salt tolerance. Additionally, they have broad antimicrobial spectra, and can significantly repress the growth of all of the tested strains of MRSA isolates, some MDRAB, ESBL E. coli, and P. aeruginosa isolates, along with food-borne pathogenic bacteria such as Bacillus cereus ATCC 11778, Listeria monocytogens ATCC 19111, Salmonella spp., Shigella spp., and Yersinia enterocolitica BCRC 12986. This is the first report of H2O2-producing L. animalis 30a-2 and W. cibaria C34 isolated from the intestinal tracts of pigs and feces of dogs that have good antimicrobial activity against multidrug-resistant and food-borne pathogenic bacteria and have excellent probiotic properties.
- Open Access
Analysis of Pollution of Phthalates in Pork and Chicken in Taiwan Using Liquid Chromatography–Tandem Mass Spectrometry and Assessment of Health Risk
Phthalates are widely used plasticizers that can cause endocrine disruption, mutagenicity, and carcinogenic effects and can contaminate food through various pathways. Investigations are scanty on phthalate pollution of livestock and poultry meat and their dietary exposure to humans. The present study assessed residual levels of phthalates in unpackaged pork (30 samples) and unpackaged chicken (30 samples) and their relevance to meat consumption and health risks in the Taiwanese population. Phthalate quantity was assessed by liquid chromatography–tandem mass spectrometry; the materials included diisononyl phthalate, diisodecyl phthalate, benzyl butyl phthalate, di-2-ethylhexyl phthalate (DEHP), and di-n-butyl phthalate. The Taiwan Food and Drug Administration (TFDA) has established values of tolerable daily intake (TDI) for the five phthalates. The major compound detected was DEHP, which ranged from 0.62 to 0.80 mg/kg in two pork samples, and 0.42–0.45 mg/kg in three chicken samples. Collectively, 8.33% of the phthalate-residue-containing samples tested positive for DEHP. The concentrations of DEHP were lower than the screening value of 1.0 mg/kg, as defined by the TFDA. Health risk was calculated as the estimated daily intake (DI) for any likely adverse effects; the DI of DEHP residues was <1% of the TDI value. The estimated risk was insignificant and considered to be safe, indicating that there is no risk to the health of Taiwanese population due to meat consumption. However, it is suggested that a phthalate monitoring program in meat should be instituted for any possible effects in future on human health.
Open AccessAnalysis of Pollution of Phthalates in Pork and Chicken in Taiwan Using Liquid Chromatography–Tandem Mass Spectrometry and Assessment of Health Risk
Phthalates are widely used plasticizers that can cause endocrine disruption, mutagenicity, and carcinogenic effects and can contaminate food through various pathways. Investigations are scanty on phthalate pollution of livestock and poultry meat and their dietary exposure to humans. The present study assessed residual levels of phthalates in unpackaged pork (30 samples) and unpackaged chicken (30 samples) and their relevance to meat consumption and health risks in the Taiwanese population. Phthalate quantity was assessed by liquid chromatography–tandem mass spectrometry; the materials included diisononyl phthalate, diisodecyl phthalate, benzyl butyl phthalate, di-2-ethylhexyl phthalate (DEHP), and di-n-butyl phthalate. The Taiwan Food and Drug Administration (TFDA) has established values of tolerable daily intake (TDI) for the five phthalates. The major compound detected was DEHP, which ranged from 0.62 to 0.80 mg/kg in two pork samples, and 0.42–0.45 mg/kg in three chicken samples. Collectively, 8.33% of the phthalate-residue-containing samples tested positive for DEHP. The concentrations of DEHP were lower than the screening value of 1.0 mg/kg, as defined by the TFDA. Health risk was calculated as the estimated daily intake (DI) for any likely adverse effects; the DI of DEHP residues was <1% of the TDI value. The estimated risk was insignificant and considered to be safe, indicating that there is no risk to the health of Taiwanese population due to meat consumption. However, it is suggested that a phthalate monitoring program in meat should be instituted for any possible effects in future on human health.
- Open Access
- 17 June 2019
- Published by MDPI AG in Applied Sciences
- Vol. 9 (12) , 2463
Health Risk Assessment of Banned Veterinary Drugs and Quinolone Residues in Shrimp through Liquid Chromatography–Tandem Mass Spectrometry
The presence of antibiotic residues in seafood and their effect on public health constitute a matter of concern for consumers worldwide. Antibiotic residues can have adverse effects on both humans and animals, especially residues of banned veterinary drugs. In this study, we applied a validated method to analyze veterinary drug residues in shrimp, including the levels of banned chloramphenicol, malachite green, leucomalachite green, and four nitrofuran metabolites as well as thiamphenicol, florfenicol, and five quinolones, which have no recommended maximum residual levels in shrimp tissues in Taiwan. We collected 53 samples of whiteleg, grass, or giant river shrimp from Taiwanese aquafarms and production areas from July 2016 to December 2017. We found 0.31 ng/g of a chloramphenicol in one grass shrimp, 5.62 ng/g of enrofloxacin in one whiteleg shrimp, 1.52 ng/g of flumequine in one whiteleg shrimp, and 1.01 ng/g of flumequine in one giant river shrimp, indicating that 7.55% of the samples contained veterinary drug residues. We evaluated the health risk by deriving the estimated daily intake (EDI). The quinolone residue EDI was below 1.0% of the acceptable daily intake recommended by the United Nations Food and Agriculture Organization and World Health Organization. The risk was thus discovered to be negligible, indicating no immediate health risk associated with shrimp consumption. The present findings can serve as a reference regarding food safety and in monitoring of the veterinary drug residues present in aquatic organisms. Continual monitoring of residues in shrimp is critical for further assessment of possible effects on human health.
- 17 June 2019
- Published by MDPI AG in Applied Sciences
- Vol. 9 (12) , 2463
Open AccessHealth Risk Assessment of Banned Veterinary Drugs and Quinolone Residues in Shrimp through Liquid Chromatography–Tandem Mass Spectrometry
The presence of antibiotic residues in seafood and their effect on public health constitute a matter of concern for consumers worldwide. Antibiotic residues can have adverse effects on both humans and animals, especially residues of banned veterinary drugs. In this study, we applied a validated method to analyze veterinary drug residues in shrimp, including the levels of banned chloramphenicol, malachite green, leucomalachite green, and four nitrofuran metabolites as well as thiamphenicol, florfenicol, and five quinolones, which have no recommended maximum residual levels in shrimp tissues in Taiwan. We collected 53 samples of whiteleg, grass, or giant river shrimp from Taiwanese aquafarms and production areas from July 2016 to December 2017. We found 0.31 ng/g of a chloramphenicol in one grass shrimp, 5.62 ng/g of enrofloxacin in one whiteleg shrimp, 1.52 ng/g of flumequine in one whiteleg shrimp, and 1.01 ng/g of flumequine in one giant river shrimp, indicating that 7.55% of the samples contained veterinary drug residues. We evaluated the health risk by deriving the estimated daily intake (EDI). The quinolone residue EDI was below 1.0% of the acceptable daily intake recommended by the United Nations Food and Agriculture Organization and World Health Organization. The risk was thus discovered to be negligible, indicating no immediate health risk associated with shrimp consumption. The present findings can serve as a reference regarding food safety and in monitoring of the veterinary drug residues present in aquatic organisms. Continual monitoring of residues in shrimp is critical for further assessment of possible effects on human health.
- Open Access
- 23 December 2016
- Published by Elsevier in Saudi Journal of Biological Sciences
- Vol. 24 (5) , 1023-1029
Efficacy of Mastoparan-AF alone and in combination with clinically used antibiotics on nosocomial multidrug-resistant Acinetobacter baumannii
- 23 December 2016
- Published by Elsevier in Saudi Journal of Biological Sciences
- Vol. 24 (5) , 1023-1029
Open AccessEfficacy of Mastoparan-AF alone and in combination with clinically used antibiotics on nosocomial multidrug-resistant Acinetobacter baumannii
- Open Access
- 11 December 2014
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 5 (5) , 3648
Correction: Laser-induced cross-linking GFP-AcmA′ bioprobe for screening Gram-positive bacteria on a biochip
Correction for ‘Laser-induced cross-linking GFP-AcmA′ bioprobe for screening Gram-positive bacteria on a biochip’ by Chuen-Fu Lin et al., RSC Adv., 2014, 4, 62882–62887.
- 11 December 2014
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 5 (5) , 3648
Open AccessCorrection: Laser-induced cross-linking GFP-AcmA′ bioprobe for screening Gram-positive bacteria on a biochip
Correction for ‘Laser-induced cross-linking GFP-AcmA′ bioprobe for screening Gram-positive bacteria on a biochip’ by Chuen-Fu Lin et al., RSC Adv., 2014, 4, 62882–62887.
- 11 November 2014
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 4 (108) , 62882-62887
Laser-induced cross-linking GFP-AcmA′ bioprobe for screening Gram-positive bacteria on a biochip
A serviceable bioprobe is one of the important components for the development of microfluidic and lab-on-a-chip systems. In this paper, we report a novel bioprobe, fabricated by laser-induced cross-linking technology, for simple and direct screening of Gram-positive bacteria on a biochip. The AcmA′ protein is known to bind specifically to peptidoglycan (PG), which forms the thick outside layer of Gram-positive bacteria. Moreover, the AcmA′ protein has a much broader spectrum of bacterium types than do antibodies that are more specific to only one bacterium type, because the AcmA′ protein is a generic characteristic of Gram-positive bacteria. Green fluorescent protein (GFP) is generally used as a molecular marker. In this study, GFP was fused with the AcmA′ protein to act as an indicator to trace the AcmA′ binding activity on PG by green fluorescence. The GFP-AcmA′ protein was three-dimensionally structured by laser-induced cross-linking photochemistry technology to fabricate a bioprobe for capturing Gram-positive bacteria. Positive and negative tests on Gram-negative Escherichia coli and Gram-positive Staphylococcus aureus and Streptococcus agalactiae were demonstrated, respectively. Screening is readily performed using optical microscopy observation. The experiments show that only Gram-positive bacteria were bound on the GFP-AcmA′ probes after minutes of incubation and phosphate buffered saline (PBS) rinsing. No binding was observed with the Gram-negative bacteria or with reference probes composed of neutral bovine serum albumin (BSA). Repeated experiments indicate that our bioprobes are reusable. Finally, a 3D wedge-shaped GFP-AcmA′ probe was demonstrated in a microfluidic channel. This study provides a novel platform for convenient Gram-positive bacteria screening that could potentially be used in lab-on-a-chip applications.
- 11 November 2014
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 4 (108) , 62882-62887
Laser-induced cross-linking GFP-AcmA′ bioprobe for screening Gram-positive bacteria on a biochip
A serviceable bioprobe is one of the important components for the development of microfluidic and lab-on-a-chip systems. In this paper, we report a novel bioprobe, fabricated by laser-induced cross-linking technology, for simple and direct screening of Gram-positive bacteria on a biochip. The AcmA′ protein is known to bind specifically to peptidoglycan (PG), which forms the thick outside layer of Gram-positive bacteria. Moreover, the AcmA′ protein has a much broader spectrum of bacterium types than do antibodies that are more specific to only one bacterium type, because the AcmA′ protein is a generic characteristic of Gram-positive bacteria. Green fluorescent protein (GFP) is generally used as a molecular marker. In this study, GFP was fused with the AcmA′ protein to act as an indicator to trace the AcmA′ binding activity on PG by green fluorescence. The GFP-AcmA′ protein was three-dimensionally structured by laser-induced cross-linking photochemistry technology to fabricate a bioprobe for capturing Gram-positive bacteria. Positive and negative tests on Gram-negative Escherichia coli and Gram-positive Staphylococcus aureus and Streptococcus agalactiae were demonstrated, respectively. Screening is readily performed using optical microscopy observation. The experiments show that only Gram-positive bacteria were bound on the GFP-AcmA′ probes after minutes of incubation and phosphate buffered saline (PBS) rinsing. No binding was observed with the Gram-negative bacteria or with reference probes composed of neutral bovine serum albumin (BSA). Repeated experiments indicate that our bioprobes are reusable. Finally, a 3D wedge-shaped GFP-AcmA′ probe was demonstrated in a microfluidic channel. This study provides a novel platform for convenient Gram-positive bacteria screening that could potentially be used in lab-on-a-chip applications.